Literature DB >> 11135048

Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.

T Moore1, A H Lee.   

Abstract

AIMS: Strong expression of CD34 and bcl-2 has been described in solitary fibrous tumours. It has been proposed that these lesions arise from long-lived mesenchymal cells. We tested the hypothesis that spindle cell lesions of the breast arise from similar mesenchymal cells in the mammary stroma. METHODS AND
RESULTS: Sections of phyllodes tumours (26), fibroadenomas (15), myofibroblastomas (two), pseudoangiomatous hyperplasia (five) and myoid hamartoma (one) were stained immunohistochemically for CD34 and bcl-2. Conventional mammary carcinoma is known to be CD34-negative: we therefore stained 11 spindle cell carcinomas and one adenosquamous carcinoma. The mammary stroma, particularly around lobules, stained for CD34. All the lesions (except the carcinomas) showed spindle cell staining for CD34. There was more staining in fibroadenomas than in phyllodes tumours (especially malignant tumours). The staining in phyllodes tumours was typically patchy. In some there was increased or decreased staining adjacent to the epithelium. There were occasional spindle cells positive for bcl-2 in the normal perilobular stroma. bcl-2 was frequently expressed in spindle cells in fibroadenomas, phyllodes tumours and pseudoangiomatous hyperplasia, and rarely in the other lesions.
CONCLUSIONS: The combined expression of CD34 and bcl-2 suggests that fibroadenomas, phyllodes tumours and pseudoangiomatous hyperplasia may arise from long-lived bcl-2-positive mesenchymal cells in the breast in a manner similar to that proposed for solitary fibrous tumours. The absence of CD34 staining in spindle cell carcinomas is of potential diagnostic value in the distinction from malignant phyllodes tumours in difficult cases.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135048     DOI: 10.1046/j.1365-2559.2001.01053.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  17 in total

1.  Male breast carcinoma of the papillary solid variant with unique CD34 positivity.

Authors:  Loannis Kostopoulos; Sotirios Barbanis; Haroula Kalekou; Stephanos Milias; Constantine S Papadimitriou
Journal:  Virchows Arch       Date:  2003-06-19       Impact factor: 4.064

2.  There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions.

Authors:  H Chauhan; A Abraham; J R A Phillips; J H Pringle; R A Walker; J L Jones
Journal:  J Clin Pathol       Date:  2003-04       Impact factor: 3.411

Review 3.  Significance of rat mammary tumors for human risk assessment.

Authors:  Jose Russo
Journal:  Toxicol Pathol       Date:  2014-05-28       Impact factor: 1.902

Review 4.  Fibroepithelial lesions revisited: implications for diagnosis and management.

Authors:  Puay Hoon Tan
Journal:  Mod Pathol       Date:  2020-05-27       Impact factor: 7.842

5.  CD34+ fibrocytes in tubular carcinomas and radial scars of the breast.

Authors:  Annette Ramaswamy; Roland Moll; Peter J Barth
Journal:  Virchows Arch       Date:  2003-07-29       Impact factor: 4.064

6.  Columnar cell lesions and pseudoangiomatous hyperplasia like stroma: is there an epithelial-stromal interaction?

Authors:  Rosemary A Recavarren; Mamatha Chivukula; Gloria Carter; David J Dabbs
Journal:  Int J Clin Exp Pathol       Date:  2009-10-10

Review 7.  Phyllodes tumours of the breast: a consensus review.

Authors:  Benjamin Y Tan; Geza Acs; Sophia K Apple; Sunil Badve; Ira J Bleiweiss; Edi Brogi; José P Calvo; David J Dabbs; Ian O Ellis; Vincenzo Eusebi; Gelareh Farshid; Stephen B Fox; Shu Ichihara; Sunil R Lakhani; Emad A Rakha; Jorge S Reis-Filho; Andrea L Richardson; Aysegul Sahin; Fernando C Schmitt; Stuart J Schnitt; Kalliopi P Siziopikou; Fernando A Soares; Gary M Tse; Anne Vincent-Salomon; Puay Hoon Tan
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

8.  Expression and role of fibroblast activation protein-alpha in microinvasive breast carcinoma.

Authors:  Xing Hua; Lina Yu; Xiaoxiao Huang; Zexiao Liao; Qi Xian
Journal:  Diagn Pathol       Date:  2011-11-08       Impact factor: 2.644

9.  Variable stromal periductular expression of CD34 and smooth muscle actin (SMA) in intraductal carcinoma of the breast.

Authors:  Xavier Catteau; Philippe Simon; Michel Vanhaeverbeek; Jean-Christophe Noël
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

10.  Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study.

Authors:  Guang-Zhi Yang; Jing Li; Hua Jin; Hua-Ye Ding
Journal:  Diagn Pathol       Date:  2013-01-28       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.